chloroquine has been researched along with Shingles in 4 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster (HZ), and the risk appears to be increased in patients treated with tofacitinib." | 7.85 | Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy. ( Bananis, E; Chen, C; Curtis, JR; Fan, H; Hirose, T; Lindsey, S; Mendelsohn, AM; Nduaka, CI; Tanaka, Y; Valdez, H; Wang, L; Winthrop, KL; Yamaoka, K, 2017) |
| "These data suggest that chloroquine diphosphate could predispose patients with dermatomyositis/polymyositis to developing herpes zoster, particularly women and dermatomyositis patients." | 7.79 | Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis. ( Cunha, GF; Levy-Neto, M; Shinjo, SK; Souza, FH, 2013) |
| "Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster (HZ), and the risk appears to be increased in patients treated with tofacitinib." | 3.85 | Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy. ( Bananis, E; Chen, C; Curtis, JR; Fan, H; Hirose, T; Lindsey, S; Mendelsohn, AM; Nduaka, CI; Tanaka, Y; Valdez, H; Wang, L; Winthrop, KL; Yamaoka, K, 2017) |
| "These data suggest that chloroquine diphosphate could predispose patients with dermatomyositis/polymyositis to developing herpes zoster, particularly women and dermatomyositis patients." | 3.79 | Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis. ( Cunha, GF; Levy-Neto, M; Shinjo, SK; Souza, FH, 2013) |
| " Six Papua New Guinean children under 9 years of age developed herpes zoster following an episode of malaria, due to Plasmodium falciparum or Plasmodium vivax which was treated with chloroquine." | 3.67 | Herpes zoster in children following malaria. ( Cook, IF, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Winthrop, KL | 1 |
| Curtis, JR | 1 |
| Lindsey, S | 1 |
| Tanaka, Y | 1 |
| Yamaoka, K | 1 |
| Valdez, H | 1 |
| Hirose, T | 1 |
| Nduaka, CI | 1 |
| Wang, L | 1 |
| Mendelsohn, AM | 1 |
| Fan, H | 1 |
| Chen, C | 1 |
| Bananis, E | 1 |
| Cunha, GF | 1 |
| Souza, FH | 1 |
| Levy-Neto, M | 1 |
| Shinjo, SK | 1 |
| Turno-Kręcicka, A | 1 |
| Tomczyk-Socha, M | 1 |
| Zimny, A | 1 |
| Cook, IF | 1 |
4 other studies available for chloroquine and Shingles
| Article | Year |
|---|---|
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Clinical Trials as Topic; Dat | 2017 |
Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Chloroquine; Dermatomyositis; | 2013 |
Progressive outer retinal necrosis syndrome in the course of systemic lupus erythematosus.
Topics: Adult; Antiviral Agents; Central Nervous System Neoplasms; Chloroquine; Chorioretinitis; Fatal Outco | 2016 |
Herpes zoster in children following malaria.
Topics: Child; Child, Preschool; Chloroquine; Female; Herpes Zoster; Humans; Immune Tolerance; Immunity, Cel | 1985 |